Anne Fletcher

Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome

Christopher S. Foster, Alison Falconer, Andrew Dodson et al. · Oncogene · 2004 · 151 citations

Medicine, Molecular Biology, Oncology +15

Overexpression of RAD51 occurs in aggressive prostatic cancer

Anita Mitra, Charles Jameson, Yolanda Barbáchano et al. · Histopathology · 2009 · 113 citations · Full text

Medicine, Genetics, Oncology +14

Nuclear overexpression of the E2F3 transcription factor in human lung cancer

Colin S. Cooper, Andrew G. Nicholson, Christopher S. Foster et al. · Lung Cancer · 2006 · 88 citations

Medicine, Genetics, Molecular Biology +14

Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer

Sakunthala C. Kudahetti, Gabrielle Fisher, Laurence Ambroisine et al. · Pathology · 2010 · 18 citations

Medicine, Oncology, Pathology +11